検索
Tonix Pharmaceuticals Holding Corp
TNXPウォッチリストに追加
11.870USD
-0.410-3.34%
終値 09-11 16:00（ET）
198.99M時価総額
損失額直近12ヶ月PER
詳細情報 Tonix Pharmaceuticals Holding Corp 企業名
Tonix Pharmaceuticals Holding Corp. is a biopharmaceutical company focused on developing and commercializing therapeutics to treat and vaccines to prevent, disease and alleviate suffering. Its development portfolio is focused on central nervous system (CNS) disorders. Its product candidates include TNX-102 SL, TNX-1300, TNX-2900, TNX-1900, TNX-1500, TNX-801, TNX-1800, TNX-4200, and TNX-1700. TNX-102 SL is for the management of fibromyalgia. Its CNS portfolio includes TNX-1300 (cocaine esterase), a biologic designed to treat cocaine intoxication that has a therapy designation. Its immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. It markets Zembrace SymTouch (sumatriptan injection) 3 mg and Tosymra (sumatriptan nasal spray) 10 mg.
Tonix Pharmaceuticals Holding Corp プロフィール
企業コードTNXP
会社名Tonix Pharmaceuticals Holding Corp
上場日Mar 29, 2010
最高経営責任者「CEO」Lederman (Seth)
従業員数81
証券種類Ordinary Share
決算期末Mar 29
本社所在地26 Main Street, Suite 101
都市CHATHAM
証券取引所NASDAQ OMX - NASDAQ BASIC
国United States of America
郵便番号07928
電話番号12129809155
ウェブサイトhttps://www.tonixpharma.com/
企業コードTNXP
上場日Mar 29, 2010
最高経営責任者「CEO」Lederman (Seth)
Tonix Pharmaceuticals Holding Corpの経営陣
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Seth Lederman, M.D.
Dr. Seth Lederman, M.D.
Chairman of the Board, President, Chief Executive Officer, Interim Chief Medical Officer
Chairman of the Board, President, Chief Executive Officer, Interim Chief Medical Officer
24.01K
+20.83%
Dr. Seth Lederman, M.D.
Dr. Seth Lederman, M.D.
Chairman of the Board, President, Chief Executive Officer, Interim Chief Medical Officer
Chairman of the Board, President, Chief Executive Officer, Interim Chief Medical Officer
24.01K
+20.83%
Dr. Seth Lederman, M.D.
Dr. Seth Lederman, M.D.
Chairman of the Board, President, Chief Executive Officer, Interim Chief Medical Officer
Chairman of the Board, President, Chief Executive Officer, Interim Chief Medical Officer
24.01K
+20.83%
Mr. Bradley Saenger, CPA
Mr. Bradley Saenger, CPA
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
2.15K
+67.46%
Mr. Bradley Saenger, CPA
Mr. Bradley Saenger, CPA
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
2.15K
+67.46%
Mr. Bradley Saenger, CPA
Mr. Bradley Saenger, CPA
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
2.15K
+67.46%
Mr. James Treco
Mr. James Treco
Lead Independent Director
Lead Independent Director
250.00
--
Mr. James Treco
Mr. James Treco
Lead Independent Director
Lead Independent Director
250.00
--
Mr. James Treco
Mr. James Treco
Lead Independent Director
Lead Independent Director
250.00
--
Dr. Gregory M. (Greg) Sullivan, M.D.
Dr. Gregory M. (Greg) Sullivan, M.D.
Secretary
Secretary
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Seth Lederman, M.D.
Dr. Seth Lederman, M.D.
Chairman of the Board, President, Chief Executive Officer, Interim Chief Medical Officer
Chairman of the Board, President, Chief Executive Officer, Interim Chief Medical Officer
24.01K
+20.83%
Dr. Seth Lederman, M.D.
Dr. Seth Lederman, M.D.
Chairman of the Board, President, Chief Executive Officer, Interim Chief Medical Officer
Chairman of the Board, President, Chief Executive Officer, Interim Chief Medical Officer
24.01K
+20.83%
Dr. Seth Lederman, M.D.
Dr. Seth Lederman, M.D.
Chairman of the Board, President, Chief Executive Officer, Interim Chief Medical Officer
Chairman of the Board, President, Chief Executive Officer, Interim Chief Medical Officer
24.01K
+20.83%
Mr. Bradley Saenger, CPA
Mr. Bradley Saenger, CPA
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
2.15K
+67.46%
Mr. Bradley Saenger, CPA
Mr. Bradley Saenger, CPA
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
2.15K
+67.46%
Mr. Bradley Saenger, CPA
Mr. Bradley Saenger, CPA
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
2.15K
+67.46%
よくある質問
Tonix Pharmaceuticals Holding Corpの上位5名の株主は誰ですか？
Tonix Pharmaceuticals Holding Corpの上位5名の株主は以下のとおりです。Dr. Seth Lederman, M.D.
Tonix Pharmaceuticals Holding Corp（TNXP）の株式を保有している機関の数はいくつですか？
2026Q1時点で、Tonix Pharmaceuticals Holding Corpの株式を保有している機関は177社あり、保有株式の総市場価値は約4.66Mで、全体の32.65%を占めています。2025Q4と比較して、機関の持ち株は2019652.00増加しています。